Drugs for Monoclonal Gammopathy of Uncertain Significance (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 55)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Celecoxib |
Approved, Investigational |
Phase 2 |
|
169590-42-5 |
2662 |
Synonyms:
4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENE-1-SULFONAMIDE
4-[5-(4-METHYLPHENYL)-3-TRIFLUOROMETHYL)-1H-PYRAZOL-YL]BENZENESULFONAMIDE
CELEBRA
Celebrex
CELECOX
Celecox®|Elyxyb® (DFN-15; oral solution)|Onsenal®|SC-58635|SC58635
Celecoxib
Célécoxib
|
Celecoxibum
Celocoxib
DFN15
DFN-15
Onsenal
p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulphonamide
SC-58635
|
|
2 |
|
Sodium fluoride |
Approved |
Phase 2 |
|
7681-49-4 |
|
Synonyms:
Fluoride, sodium
Fluorides, sodium
Fluorinse
Fluoristat
Fluoristats
NaF
Ossin
|
Ossins
Procter and gamble brand OF sodium fluoride
Sodium fluoride
Sodium fluorides
Zymafluor
Zymafluors
|
|
3 |
|
Curcumin |
Approved, Investigational |
Phase 2 |
|
458-37-7, 84765-67-3 |
969516 |
Synonyms:
1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione
1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione
1,9-Bis(4-hydroxy-3-methoxyphenyl)-2,7-nonadiene-4,6-dione
14a-Methyl-9,19-cyclo-5a,9b-cholestane-3b,6a-diol
C.I. 75300
C.I. natural yellow 3
CI natural yellow 3
CI-75300
Cucurmin
Curcuma
CURCUMIN
Curcumin I
Diferaloylmethane
Diferuloylmethane
e 100
E100
E-100
Gelbwurz
Golden seal
Haidr
Halad
Haldar
Halud
|
Hydrastis
INS NO. 100(I)
INS-100(I)
Kacha haldi
Merita earth
Natural yellow 3
NSC-32982
NSC-687842
Orange root
Safran d'inde
Souchet
Terra merita
Tumeric yellow
Turmeric
Turmeric (>98% curcurmin)
Turmeric oleoresin (79%-85% curcumin)
Turmeric yellow
Yellow ginger
Yellow puccoon
Yellow root
Yellow, turmeric
Yo-kin
|
|
4 |
|
Metformin |
Approved |
Phase 2 |
|
1115-70-4, 657-24-9 |
4091 |
Synonyms:
[<sup>14</sup>C]-metformin
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
1-CARBAMIMIDAMIDO-N,N-DIMETHYLMETHANIMIDAMIDE
Apo-Metformin
BOLAMYN SR
Diabefagos
Diabex
Diaformin
DIAGEMET XL
Dianben
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
DMBG
Fortamet
Gen-Metformin
GLUCAMET 500
GLUCAMET 850
GLUCIENT SR
Glucophage
GLUCOPHAGE SR
GLUCOPHAGE XR
Glumetza
Glycon
GLYFORMIN
HCL, Metformin
Hydrochloride, metformin
JANUMET
LA 6023
LA-6023
|
LEDERMETIN
Meguan
METABET SR
Metformin
Metformin HCL
Metformin hydrochloride
Metformina
Metformine
Metforminum
Metiguanide
METSOL
MILFORM
Mylan-Metformin
N(1),N(1)-Dimethylbiguanide
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-Dimethylguanylguanidine
N,N-Dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
Novo-Metformin
NSC-91485
Nu-Metformin
Obimet
ORABET
PMS-Metformin
Ran-Metformin
Ratio-Metformin
Riomet
Sandoz Metformin
SUKKARTO SR
Teva-Metformin
XLA399
|
|
5 |
|
Acetaminophen |
Approved |
Phase 2 |
|
103-90-2 |
1983 |
Synonyms:
4-(Acetylamino)phenol
4-Acetamidophenol
4-Acetaminophenol
4'-Hydroxyacetanilide
4-Hydroxyacetanilide
4-Hydroxyanilid kyseliny octove
A.F. anacin
ABDINE
Abenol
Abensanil
Abrol
Abrolet
Acamol
Accu-tap
Acenol
Acephen
Acertol
Aceta elixir
Aceta tablets
Acetaco
Acetagesic
Acetalgin
Acetamidophenol
Acetaminofen
ACETAMINOFÉN
ACETAMINOPHEN
Acetaminophen uniserts
acetaminophen|Panadol®|Tylenol®
Acetaminophene
ACÉTAMINOPHÈNE
Acetamol
Acetofen
Acetominophen
Actamin
Actamin extra
Actamin super
Actifed plus
Actimol
Actimol chewable tablets
Actimol children's suspension
Actimol infants' suspension
Actimol junior strength caplets
Actron
Afebrin
Afebryl
Aferadol
Algesidal
Algina
Algomol
Algotropyl
Allay
alpha-Per
Alpiny
Alpinyl
Alvedon
Amadil
Aminofen
Aminofen max
Anacin
Anacin 3
Anacin3
Anacin-3
Anacin-3 extra strength
Anadin dla dzieci
Anaflon
Analter
Anapap
Andox
Anelix
Anexsia
Anexsia 10/660
Anexsia 5/325
Anexsia 7.5/325
Anexsia 7.5/650
ANGIERS
Anhiba
Anoquan
Anti-algos
Antidol
Apacet
Apacet capsules
Apacet elixir
Apacet extra strength caplets
Apacet extra strength tablets
Apacet regular strength tablets
Apadon
Apamid
Apamide
APAP
a-Per
Apitrelal
Apo-acetaminophen
Arfen
Asetam
Asomal
Aspac
Aspirin free anacin maximum strength caplets
Aspirin free anacin maximum strength gel caplets
Aspirin free anacin maximum strength tablets
Aspirin-free anacin
Aspirin-free excedrin caplets
Asplin
Atasol
Atasol caplets
Atasol drops
Atasol forte caplets
Atasol forte tablets
Atasol oral solution
Atasol tablets
Atralidon
Babikan
Bacetamol
Bancap
Bancap HC
Banesin
Bayer Select
Bayer select allergy-sinus
Bayer select head cold
Bayer select headache pain
Bayer select maximum strength headache pain relief formula
Bayer select menstrual multi-symptom
Bayer select sinus pain relief
Benmyo
Ben-u-ron
Bickie-mol
Biocetamol
Bucet
Butalbital
Butapap
Cadafen
Calapol
Calmanticold
Calpol
CALPOL SIX PLUS
CALPOL SIX PLUS FASTMELTS
Capital with codeine
Captin
Causalon
Cefalex
Cetadol
CHILD LEMSIP
Children'S acetaminophen elixir drops
Children'S acetaminophen oral solution
Children'S tylenol chewable
Claradol codeine
Clixodyne
Codabrol
COD-Acamol forte
Codalgin
Codapane
Codicet
Codisal
Codisal forte
Codoliprane
Codral pain relief
Cofamol
CO-Gesic
Conacetol
Contac cough & sore throat formula
Contra-schmerz p
Coricidin
Coricidin D
Coricidin sinus
Cosutone
Croix blanche
CUPANOL
Cuponol
Curadon
Curpol
Custodial
DAFALGAN
Dapa
Dapa X-S
Darocet
Darvocet
Darvocet-N 50
Datril
Datril extra-strength
Daygrip
Demilets
Deminofen
Democyl
Demogripal
Desfebre
Dhamol
DHC Plus
Dial-a-gesic
Dial-alpha-gesic
Dimindol
Dirox
Disprol
DISPROL INFANT
DISPROL JNR
DISPROL PAED
Dolcor
Dolefin
Dolegrippin
Dolene ap-65
Dolgesic
Doliprane
Dolko
Dolofugin
Doloreduct
Dolorfug
Dolorol forte
Dolorstop
Dolotec
Dolprone
Dol-stop
Dorocoff
Dresan
Dristan cold no drowsiness
Dristancito
Drixoral Plus
Dularin
Duracetamol
Duradyne DHC
Durapan
Dymadon
Dymadon co
Dymadon forte
Dypap
Ecosetol
Elixodyne
Empracet
Endecon
Enelfa
Eneril
Esgic
Esgic-plus
Eu-med
Excedrin
Excedrin caplets
Excedrin extra strength caplets
Excipain
Exdol
Exdol strong
Fanalgic
Farmadol
Febranine
Febrectal
Febrectol
Febrex
Febricet
Febridol
Febrilix
Febrin
Febrinol
Febro-gesic
Febrolin
Femcet
Fendon
FENNINGS
Fensum
Fepanil
Feverall
Feverall junior strength
Feverall sprinkle caps junior strength
Fevor
Finimal
Finiweh
Fioricet
Fluparmol
Fortalidon p
Freka-cetamol
GALPAMOL
Gattaphen T
Gelocatil
Geluprane
Genapap
Genapap children's elixir
Genapap children's tablets
Genapap extra strength caplets
Genapap extra strength tablets
Genapap regular strength tablets
Genebs
Genebs extra strength caplets
Genebs regular strength tablets
Genebs X-tra
Geralgine-p
Gripin bebe
Grippostad
Gynospasmine
Hedex
Helon N
Homoolan
Hycomine compound
Hydrocet
Hydroxyacetanilide
Hy-phen
Ildamol
Inalgex
Infadrops
Infants' feverall
Influbene N
Injectapap
Intensin
Janupap
Junior disprol
JUNIOR PARAPAED
Kataprin
Kinder finimal
Korum
Kratofin simplex
Labamol
Lekadol
Lemgrip
Lemsip
Lestemp
Liquagesic
Liquigesic co
Liquiprin
Liquiprin children's elixir
Liquiprin infants" drops
Lonarid
Lonarid mono
Lorcet-HD
Lortab
Lupocet
Lyteca
Lyteca syrup
Magnidol
Malex N
Malgis
Malidens
MANDANOL
Maxadol
Medigesic plus
MEDINOL
MEDINOL FOR CHILDREN
MEDINOL OVER 6
Medinol paediatric
MEDINOL UNDER 6
MEDISED PLAIN
Medocodene
Melabon infantil
Mexalen
Midol maximum strength
Midol PM night time formula
Midol regular strength
Midol teen formula
Migraleve yellow
Minafen
Minoset
MIRADOL
Miralgin
Momentum
|
mono Praecimed
Multin
N-(4-Hydroxyphenyl)acetamide
N-(4-Hydroxyphenyl)acetanilide
N-Acetyl-4-aminophenol
N-Acetyl-p-aminophenol
Naldegesic
NAPA
Napafen
Napap
Naprinol
Nealgyl
Nebs
NeoCitran
Neodol
Neodolito
Neo-fepramol
Neopap
Neotrend
Neuridon
New cortal for children
NilnOcen
Nina
Nobedon
Nodolex
NO-Febril
Noral
Norcet
Norco
NSC-109028
NSC-3991
O-Acetaminophenol
OFIRMEV
Oltyl
Oralgan
Oraphen-PD
Ortensan
Oxycet
Oxycocet
Oxycodone 2.5/apap 500
Oxycodone 5/apap 500
p-(Acetylamino)phenol
Paceco
Pacemo
Pacemol
Pacet
p-Acetamidophenol
p-Acetaminophenol
p-Acetylaminophenol
Pacimol
Paedialgon
Paedol
Painex
Paldesic
Pamol
Panacete
Panadeine
Panadeine co
Panadiene
PANADO
Panado-co
Panado-co caplets
Panadol
PANADOL ACTIFAST
PANADOL ACTIFAST SOLB
PANADOL ADVAN
Panadol extra strength
PANADOL JNR
Panadol junior strength caplets
Panadol maximum strength caplets
Panadol maximum strength tablets
PANADOL OA
Panaleve
PANALEVE 6 PLUS
Panamax
Panasorb
Panasorbe
Panets
Panex
Panodil
Panofen
Pantalgin
Papa-Deine
Papa-deine #3
Papa-deine #4
Paracemol
Paracenol
Paracet
Paracetamol
PARACÉTAMOL
Paracetamol al
Paracetamol antipanin p
Paracetamol basics
Paracetamol BC
Paracetamol DC
Paracetamol dr. schmidgall
Paracetamol fecofar
Paracetamol genericon
Paracetamol hanseler
Paracetamol harkley
Paracetamol heumann
Paracetamol hexal
Paracetamol italfarmaco
Paracetamol nycomed
Paracetamol PB
Paracetamol raffo
Paracetamol ratiopharm
Paracetamol rosch
Paracetamol saar
Paracetamol smithkline beecham
Paracetamol stada
Paracetamol von CT
Paracetamol winthrop
Paracetamole
Paracetamolo
Paracetamolum
Paracetanol
Paracetol
Paracin
Paracod
Paracodol
Parador
Paradrops
Parakapton
Parake
Paralen
Paralief
Paralink
Paralyoc
PARAMIN
Paramol
Paramolan
Paranox
PARAPAED JNR
PARAPAED SIX PLUS
Parapan
Parasedol
Parasin
Paraspen
Para-suppo
Para-tabs
PARAVICT
Parcetol
Parelan
Parmol
Parogal
Paroma
Pasolind
Pasolind N
PCM Paracetamol lichtenstein
Pediapirin
Pediatrix
Pedric
Percocet
Percocet-5
Percocet-demi
Percogesic with codeine
Perdolan mono
PERFALGAN
Pe-tam
Phenaphen
Phenaphen caplets
Phenaphen w/codeine
Phendon
Phenipirin
Phogoglandin
Phrenilin
Phrenilin forte
P-HYDROXY-ACETANILID
p-Hydroxyacetanilide
p-Hydroxyphenolacetamide
Pinex
Piramin
Pirinasol
PLACIDEX
Plicet
Polmofen
Predimol
Predualito
Prestwick_13
Prodol
Prompt
Prontina
Propacet
Propacet 100
Proval #3
Puernol
Pulmofen
Pyregesic-C
Pyrigesic
Pyrinazine
Pyromed
Quiet world
Redutemp
Reliv
Remedol
Rhinex D-lay tablets
RIMADOL
Rivalgyl
Robigesic
Robitussin night relief
Rockamol plus
Rounox
Roxicet
Roxicet 5/500
Roxilox
RubieMol
Rubophen
Rupemol
Salzone
Sanicet
Sanicopyrine
Scanol
Scentalgyl
Scherzatabletten rezeptur 534
Schmerzex
Sedalito
Sedapap
Semolacin
Servigesic
Seskamol
Setakop
Setamol
Setol
Sifenol
Sinaspril
Sinedol
Sine-OFF sinus medicine caplets
Sinmol
Sinubid
SK-Apap
Snaplets-FR
Spalt fur die nacht
Spalt N
ST Joseph aspirin-free
ST Joseph aspirin-free for children
St. joseph cold tablets for children
St. joseph fever reducer
Stanback
Stopain
Sudafed severe cold formula
Sudafed sinus
Sunetheton
Supac
Supadol mono
Supofen
Suppap
Suppap-120
Suppap-325
Suppap-650
Supramol-m
Synalgos-DC-a
Tabalgin
Tachiprina
Talacen
Tapanol
Tapanol extra strength caplets
Tapanol extra strength tablets
Tapar
Tavist allergy/sinus/headache
Tazamol
Temlo
Tempanal
Tempra
Tempra caplets
Tempra chewable tablets
Tempra d.s
Tempra drops
Tempra syrup
Tencon
Termacet
Termalgin
Termalgine
Termofren
TheraFlu
Tibinide
Tibizide
Tiffy
Tisin
Tisiodrazida
Titralgan
TIXYMOL
Tizide
Tocris-1706
Toximer p
Tralgon
TRAMIL 500
Treupel mon
Treupel N
Treuphadol
Triad
Triaminic sore throat formula
Triaprin
Tricoton
Tussapap
Tycolet
TYL
Tylenol
Tylenol allergy sinus
Tylenol arthritis extended relief
Tylenol caplets
Tylenol children's chewable tablets
Tylenol children's elixir
Tylenol children's suspension liquid
Tylenol drops
Tylenol elixir
Tylenol extra strength adult liquid pain reliever
Tylenol extra strength caplets
Tylenol extra strength gelcaps
Tylenol extra strength tablets
Tylenol gelcaps
Tylenol infants drops
Tylenol infants" suspension drops
Tylenol junior strength caplets
Tylenol junior strength chewable tablets
Tylenol regular strength caplets
Tylenol regular strength tablets
Tylenol tablets
Tylex
Tylex CD
Tylol
Tylox
Tylox-325
Tymol
Ultracet
Upsanol
Utragin
Valadol
Valgesic
Valorin
Valorin extra
Vanquish
Veralgina
Vermidon
Verpol
Viclor richet
Vicodin
Vicodin es
Vicodin HP
Vips
Viruflu
Vivimed
Volpan
Wygesic
Zatinol
Zolben
|
|
6 |
|
Acalabrutinib |
Approved, Investigational |
Phase 2 |
|
1420477-60-6 |
71226663 71226662 |
Synonyms:
ACALABRUTINIB
Acalabrutinibum
ACP-196
|
ACP-196|Calquence®|Example 6 [US20140155385 A1]
CALQUENCE
EXAMPLE 6 [US20140155385 A1]
|
|
7 |
|
Daratumumab |
Approved |
Phase 2 |
|
945721-28-8 |
|
Synonyms:
3003-005
3003-005|Darzalex®|HuMax-CD38|JNJ-54767414
DARATUMUMAB
|
|
|
8 |
|
Lenalidomide |
Approved |
Phase 2 |
|
191732-72-6 |
216326 |
Synonyms:
1-oxo-2-(2,6-Dioxopiperidin-3-yl)-4-aminoisoindoline
3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione
CC-5013
CC-5013|CDC-501|Revlimid®
CDC 501
CDC-501
Celgene brand OF lenalidomide
IMID-1
|
IMiD3
IMiD3 CPD
Lenalidomida
LENALIDOMIDE
Revimid
Revlimid
SYP-1512
|
|
9 |
|
Cianidanol |
Approved, Withdrawn |
Phase 2 |
|
154-23-4 |
9064 |
Synonyms:
(-)-Epicatechin
(+)-(2R,3S)-5,7,3',4'-Tetrahydroxyflavan-3-ol
(+)-(2R:3S)-5,7,3',4'-Tetrahydroxyflavan-3-ol
(+)-(2R:3S)-5,7,3’,4’-Tetrahydroxyflavan-3-ol
(+)-3',4',5,7-Tetrahydroxy-2,3-trans-flavan-3-ol
(+)-3’,4’,5,7-Tetrahydroxy-2,3-trans-flavan-3-ol
(+)-Catechin
(+)-Catechin hydrate
(+)-Catechol
(+)-Cianidanol
(+)-Cyanidan-3-ol
(+)-Cyanidanol
(+)-Cyanidanol-3
(+/-)-catechin
(+/-)-catechin hydrate
(2R,3S)-(+)-Catechin
(2R,3S)-Catechin
(2R-trans)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol
3,3',4',5,7-Flavanpentol
Acid, catechinic
Acid, catechuic
Biocatechin
CATECHIN
Catechinate
|
Catechinic acid
Catechuate
Catechuic acid
Catergen
Cianidanol
Cianidanolum
Cianidol
Cyanidanol
Cyanidanol 3
Cyanidanol-3
Cyanidol
D-(+)-Catechin
D-Catechin
D-Catechol
Dexcyanidanol
Epicatechin
KB 53
KB-53
trans-(+)-3,3',4',5,7-Flavanpentol
trans-(+)-3,3’,4’,5,7-Flavanpentol
trans3,3,4,5,7 Pentahydroxyflavane
YK-85 light yellow powder 85
Zyma
|
|
10 |
|
Rituximab |
Approved |
Phase 2 |
|
174722-31-7 |
|
Synonyms:
ABP-798
ANTICD20
CT-P10
HS006
HS-006
HS-006 (RITUXIMAB BIOSIMILAR)
HSDB 7455|IDEC-C2B8|MabThera®|Rituxan®
IDEC-102
IDEC-C2B8
IG GAMMA-1 CHAIN C REGION
Ig gamma-2A chain C region, membrane-bound form
MABTHERA
MABTHERA RITUXAN
|
R-105 IDEC-102
radiolabeled murine anti-CD20
RG-105
RHCACD20MA
RITUXAN
RITUXIMAB
rituximab-abbs
rituximab-arrx
rituximab-pvvr
SAIT101
SAIT-101
Zevalin
|
|
11 |
|
Piperine |
Investigational |
Phase 2 |
|
94-62-2 |
638024 |
Synonyms:
((1-5-(1,3)-Benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)piperidine
(1-(5-(1,3)-Benzodioxol-5-yl)-1-oxo-2,4-pentadienyl)piperidine
(e,e)-1-Piperoylpiperidine
1-[(2E,4E)-5-(1,3-Benzodioxol-5-yl)-1-oxo-2,4-pentadienyl]piperidine
1-[(2E,4E)-5-(1,3-Benzodioxol-5-yl)-2,4-pentadienoyl]piperidine
1-Piperoyl-(e,e)-piperidine
1-Piperoylpiperidine
1-Piperoyl-piperidine
Bioperine
FEMA 2909
FEMA NO. 2909
|
N-(e,e)-Piperoyl-piperidine
N-[(e,e)-Piperoyl]piperidine
N-Ee-piperoyl-piperidine
NSC-21727
Piperin
PIPERINE
Piperine, (e,e)-isomer
Piperine, (e,Z)-isomer
Piperine, (Z,e)-isomer
Piperine, (Z,Z)-isomer
|
|
12 |
|
Epigallocatechin gallate |
Investigational |
Phase 2 |
|
989-51-5 |
65064 |
Synonyms:
(-)-Epigallocatechin gallat
(-)-EPIGALLOCATECHIN GALLATE
(-)-EPIGALLOCATECHIN-3-O-GALLATE
(-)-Epigallocatechin-3-O-gallic acid
(-)-Epigallocatechol gallate
(-)-Epigallocatehin gallate
[(2R,3R)-5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-3,4-DIHYDRO-2H-CHROMEN-3-YL] 3,4,5-TRIHYDROXYBENZOATE
[(2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoic acid
Catechin deriv.
egcg
EGCG CPD
EGCG|epigallocatechin gallate
Epigallocatcchin gallate
Epigallocate
|
Epigallocatechin 3-gallate
Epigallocatechin 3-gallic acid
Epigallo-catechin gallate
EPIGALLOCATECHIN GALLATE
EPIGALLOCATECHIN GALLATE,EGCG
Epigallocatechin gallic acid
Epigallocatechin-3-gallate
Epigallocatechin-3-O-gallate
Epigallocic acid
EPIGALOCATECHIN GALLATE
Galloyl-L-epigallocatechol
Sunphenon
Tea catechin
|
|
13 |
|
Epigallocatechin |
Experimental, Investigational |
Phase 2 |
|
970-74-1 |
72277 |
Synonyms:
(-)-3,3',4',5,5',7-Flavanhexol
(-)-3,3’,4’,5,5’,7-Flavanhexol
(-)-cis-3,3',4',5,5',7-Hexahydroxyflavan
(-)-cis-3,3',4',5,5',7-Hexahydroxyflavane
(−)-epigallocatechin
(-)-epi-Gallocatechin
(-)-Epigallocatechin
(-)-Epigallocatechol
(2R,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol
(2R,3R)-2-(3,4,5-Trihydroxyphenyl)-3,5,7-trihydroxychroman
(2R,3R)-3,4-Dihydro-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3,5,7-triol
1-epi-3',4',5',5,7-Pentahydroxy-3-flavanol
1-epi-3’,4’,5’,5,7-Pentahydroxy-3-flavanol
2,3-cis-Epigallocatechin
|
3,3',4',5,5',7-Flavanhexol
3,3’,4’,5,5’,7-Flavanhexol
Antiscurvy factor C2
EGC
epi-Gallocatechin
Epigallocatechin
Epigallocatechol
Gallocatechin
Gallocatechol
Gallocatechol, (2R-cis)-isomer
Gallocatechol, (2R-trans)-isomer
Galloepicatechin
L-Epigallocatechin
l-Epigallocatechol
|
|
14 |
|
Epicatechin |
Investigational |
Phase 2 |
|
490-46-0 |
58571364 72276 |
Synonyms:
(-)-Epicatechin
(-)-Epicatechol
(+)-Catechin
(+)-Cyanidanol
(+)-Cyanidanol-3
(2R,3R)-(-)-Epicatechin
3,3',4',5,7-Flavanpentol
3,3',4',5,7-Pentahydroxyflavane
Acid, catechinic
Acid, catechuic
alpha-Catechin
Catechin
Catechinic acid
Catechuic acid
Catergen
Cianidanol
Cyanidanol 3
|
Cyanidanol-3
EC
Epicatechin
Epi-catechin
Epicatechin-(2a->7,4a->8)-epicatechin 3-galactoside
Epicatechin-(2α->7,4α->8)-epicatechin 3-galactoside
Epicatechol
Epigallocatechin
KB 53
KB-53
L(-)-Epicatechin
L-Acacatechin
L-Epicatechin
L-Epicatechol
NSC-81161
Zyma
|
|
15 |
|
Vaccines |
|
Phase 2 |
|
|
|
16 |
|
Cyclooxygenase Inhibitors |
|
Phase 2 |
|
|
|
17 |
|
Cyclooxygenase 2 Inhibitors |
|
Phase 2 |
|
|
|
18 |
|
Radiopharmaceuticals |
|
Phase 2 |
|
|
|
19 |
|
Listerine |
|
Phase 2 |
|
|
|
20 |
|
Fluorodeoxyglucose F18 |
|
Phase 2 |
|
|
|
21 |
|
Fluorides |
|
Phase 2 |
|
|
|
22 |
|
Chelating Agents |
|
Phase 2 |
|
|
|
23 |
|
Antibodies, Monoclonal |
|
Phase 2 |
|
|
|
24 |
|
Analgesics |
|
Phase 2 |
|
|
|
25 |
|
Anti-Inflammatory Agents, Non-Steroidal |
|
Phase 2 |
|
|
|
26 |
|
Analgesics, Non-Narcotic |
|
Phase 2 |
|
|
|
27 |
|
Anti-Inflammatory Agents |
|
Phase 2 |
|
|
|
28 |
|
Cytochrome P-450 Enzyme Inhibitors |
|
Phase 2 |
|
|
|
29 |
|
Histamine H1 Antagonists |
|
Phase 2 |
|
|
|
30 |
|
Histamine Antagonists |
|
Phase 2 |
|
|
|
31 |
|
Immunoglobulins |
|
Phase 2 |
|
|
|
32 |
|
Antibodies |
|
Phase 2 |
|
|
|
33 |
|
Omega 3 Fatty Acid |
|
Phase 2 |
|
|
|
34 |
|
Angiogenesis Inhibitors |
|
Phase 2 |
|
|
|
35 |
|
Immunologic Factors |
|
Phase 2 |
|
|
|
36 |
|
Antirheumatic Agents |
|
Phase 2 |
|
|
|
37 |
|
Neuroprotective Agents |
|
Phase 2 |
|
|
|
38 |
|
Antioxidants |
|
Phase 2 |
|
|
|
39 |
|
Tea |
|
Phase 2 |
|
|
|
40 |
|
Protective Agents |
|
Phase 2 |
|
|
|
41 |
|
Antineoplastic Agents, Immunological |
|
Phase 2 |
|
|
|
42 |
|
Siltuximab |
Approved, Investigational |
Phase 1 |
|
541502-14-1 |
|
Synonyms:
|
43 |
|
Rifaximin |
Approved, Investigational |
Phase 1 |
|
80621-81-4 |
46783403 6436173 |
Synonyms:
(7S,9Z,11S,12R,13S,14R,15R,16R,17S,18S,19Z,21Z)-2,15,17,23,36-Pentahydroxy-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-6-oxo-8,37-dioxa-24,27,33-triazahexacyclo[23.10.1.1,.0,.0,.0,]heptatriaconta-1(35),2,4,9,19,21,23,25(36),26(34),28,30,32-dodecaen-13-yl acetic acid
4-Deoxy-4'-methylpyrido(1',2'-1,2)imidazo(5,4C)rifamycin
NORMIX
Redactiv
RIFACOL
RIFAMYCIN L 105
RIFAMYCIN L 105SV
RIFAXIDIN
Rifaximin
|
RIFAXIMINA
RIFAXIMINE
RIFAXIMINUM
RIFAXIMINUN
TARGAXAN
Xifaxan
XIFAXANTA
XIFAXSAN
|
|
44 |
|
Liver Extracts |
|
Phase 1 |
|
|
|
45 |
|
Imatinib Mesylate |
|
Phase 1 |
|
220127-57-1 |
|
Synonyms:
GLEEVEC
GLIVEC
IMATINIB MESILATE
IMATINIB MESYLATE
|
IMATINIB METHANESULFONATE
STI571
STI-571
|
|
46 |
|
Protein Kinase Inhibitors |
|
Phase 1 |
|
|
|
47 |
|
Anti-Bacterial Agents |
|
Phase 1 |
|
|
|
48 |
|
Anti-Infective Agents |
|
Phase 1 |
|
|
|
49 |
|
Gastrointestinal Agents |
|
Phase 1 |
|
|
|
50 |
|
Altretamine |
Approved |
Early Phase 1 |
|
645-05-6 |
2123 |
Synonyms:
2,4,6-Tris(dimethylamino)-1,3,5-triazine
2,4,6-Tris(dimethylamino)-S-triazine
ALTRETAMIN
Altretamina
Altretamine
ALTRÉTAMINE
Altretamine bellon brand
Altretamine chiesi brand
Altretamine wassermann brand
Altretaminum
Bellon brand OF altretamine
Chiesi brand OF altretamine
Hemel
|
Hexalen
HEXAMETHYLMELAMINE
Hexastat
Hexinawas
HMM
HTM
HXM
MGI pharma brand OF altretamine
NSC-13875
Rhône poulenc rorer brand OF altretamine
Rhône-poulenc rorer brand OF altretamine
Wassermann brand OF altretamine
|
|
Interventional clinical trials:
(show top 50)
(show all 59)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Reduction of Antigen-Lipid-Driven Monoclonal Gammopathies by Targeting Epicardial Fat and Its Lipids Content With Liraglutide: A Glucagon Like Peptide-1 Receptor Analogue (GLP-1RA) |
Withdrawn |
NCT02920190 |
Phase 4 |
Liraglutide |
2 |
Double-blind Randomized Trial of Rituximab Versus Placebo in Polyneuropathy Associated With Anti-MAG IgM Monoclonal Gammopathy |
Completed |
NCT00259974 |
Phase 3 |
Rituximab |
3 |
Biologic and Clinical Role of COX-2 Inhibitor (Celecoxib)in the Management of MGUS and Smoldering Myeloma |
Completed |
NCT00099047 |
Phase 2 |
celecoxib;placebo |
4 |
A Pilot Study of Novel Imaging Modalities in Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM), and Multiple Myeloma (MM) |
Completed |
NCT01237054 |
Phase 2 |
18-NaF PET;18-FDG PET/CT |
5 |
Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients (SHIVERING 2) |
Completed |
NCT02566265 |
Phase 2 |
|
6 |
A Single Arm, Multicenter, Phase II, Open-Label Trial to Evaluate Efficacy of Isatuximab in Patients With Monoclonal Gammopathy of Renal Significance |
Recruiting |
NCT04614558 |
Phase 2 |
Isatuximab |
7 |
Efficacy of Curcumin and Piperine in Patients on Active Surveillance for Either Monoclonal Gammopathy of Unknown Significance (MGUS), Low-risk Smoldering Multiple Myeloma (SMM) or Early Stage Prostate Cancer: A Pilot Study |
Recruiting |
NCT04731844 |
Phase 2 |
Curcumin plus Piperine |
8 |
A Randomized Placebo-Controlled Phase 2 Study of Metformin for the Prevention of Progression of Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma |
Recruiting |
NCT04850846 |
Phase 2 |
Metformin XR |
9 |
Phase II Study on Acalabrutinib and Anti-CD20 Antibody in Patients With Anti-MAG Mediated Neuropathy |
Recruiting |
NCT05065554 |
Phase 2 |
Acalabrutinib;Rituximab |
10 |
Randomized Double-Blind Phase 2 Trial of Ibrutinib Versus Standard Treatment for COVID-19 Illness Requiring Hospitalization With Safety Lead-In |
Active, not recruiting |
NCT04439006 |
Phase 2 |
Ibrutinib |
11 |
A Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma |
Active, not recruiting |
NCT03236428 |
Phase 2 |
Daratumumab |
12 |
Isatuximab in Type I Cryoglobulinemia: A Prospective Pilot Study |
Not yet recruiting |
NCT05114109 |
Phase 2 |
Isatuximab Injection |
13 |
A Phase II Trial of Lenalidomide as a Treatment for Neuropathy Associated With Nonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS) |
Terminated |
NCT00665652 |
Phase 2 |
Lenalidomide |
14 |
The Clinical and Biologic Evaluation of Polyphenon E, an Extract of Green Tea Containing EGCG, in Plasma Cell Dyscrasias - Pilot Study |
Terminated |
NCT00942422 |
Phase 2 |
|
15 |
Inhibition of Nuclear Factor Kappa B for Prevention of Disease Progression in Indolent B Cell Malignancies |
Terminated |
NCT00899353 |
Phase 2 |
|
16 |
A Phase II Trial of Rituximab for Peripheral Neuropathy Associated With Monoclonal Gammopathy of Undetermined Significance (MGUS) |
Terminated |
NCT00588822 |
Phase 2 |
|
17 |
Novel Imaging Modalities to Characterize Angiogenesis in the Bone Marrow Microenvironment in Multiple Myeloma (MM) and Its Precursor Disease |
Withdrawn |
NCT01571726 |
Phase 2 |
Fluciclatide |
18 |
A Phase I Pharmacokinetic Study of STI571 in Patients With Advanced Malignancies and Varying Levels of Liver Dysfunction |
Completed |
NCT00025415 |
Phase 1 |
imatinib mesylate |
19 |
A Study of Siltuximab (Anti-IL-6 Monoclonal Antibody) Effects on the QT Interval in Subjects With Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Indolent Multiple Myeloma |
Completed |
NCT01219010 |
Phase 1 |
|
20 |
Pilot Study of Oral Rifaximin in Patients With Monoclonal Gammopathy |
Recruiting |
NCT03820817 |
Phase 1 |
Rifaximin |
21 |
A Phase I Trial to Evaluate Safety and Immunogenicity of a Cytomegalovirus Peptide Vaccine Co-Injected With PF-03512676 Adjuvant in Recipients of Allogeneic Hematopoietic Stem Cell Transplant |
Active, not recruiting |
NCT01588015 |
Phase 1 |
|
22 |
Immunologic and Genetic Characteristics of Monoclonal Immunoglobulins in Patient With Tuberculosis |
Unknown status |
NCT00173264 |
|
|
23 |
Diagnosis of Monoclonal Gammopathy of Renal Significance in Patients With Paraproteinemias |
Unknown status |
NCT03629561 |
|
|
24 |
Understanding Monoclonal Gammopathy of Unknown Significance (MGUS): A Research Study to Investigate the Functional Consequences of Paraprotein Production in MGUS |
Unknown status |
NCT02933021 |
|
|
25 |
Frequency and Characteristics of Pruritus in Patients With Monoclonal Gammopathy |
Completed |
NCT03832140 |
|
|
26 |
A Diagnostic Screening Trial Seeking AL Amyloidosis Very Early |
Completed |
NCT02741999 |
|
|
27 |
Genomic and Psychosocial Effects of the Relaxation Response Resiliency Program (3RP) on Patients With MGUS and Smoldering Multiple Myeloma |
Completed |
NCT01955395 |
|
|
28 |
S0309, Myeloma Specimen Repository Protocol, Ancillary |
Completed |
NCT00919139 |
|
|
29 |
S0120, A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders |
Completed |
NCT00900263 |
|
|
30 |
The Development and Pilot Testing of a New Magnetic Resonance (MR) Imaging Protocol to Quantify Both Myeloma Disease Burden and Associated Bone Loss |
Completed |
NCT03951220 |
|
|
31 |
Prognostic Study of Markers of Angiogenesis and Coagulability in Patients With Monoclonal Gammopathy |
Completed |
NCT01543100 |
|
|
32 |
A Prospective Study Of Circulating Multiple Myeloma Cells As A Biomarker Of Progression In Myeloma Precursor States (MGUS And SMM) |
Completed |
NCT01958528 |
|
|
33 |
Study of Biomarkers of Exposure and Effects in Agriculture |
Completed |
NCT01139476 |
|
|
34 |
Sleep Apnea in Patients With MGUS and MM |
Recruiting |
NCT04114084 |
|
|
35 |
Screening to Improve Survival in AL Amyloidosis |
Recruiting |
NCT04615572 |
|
|
36 |
Study of Precursor Hematological Malignancies to Assess the Relationship Between Molecular Events of Progression and Clinical Outcome |
Recruiting |
NCT02269592 |
|
|
37 |
Prospective Observational Study of Clinical and Genomic Predictors of Progression to Myeloma in Asymptomatic Monoclonal Gammopathies |
Recruiting |
NCT02726750 |
|
|
38 |
A Randomized Placebo Controlled Study of a Plant-Based Dietary Versus Supplement Versus Placebo Intervention in Patients With Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple Myeloma (SMM) - The Nutrition Prevention (NUTRIVENTION3) Study |
Recruiting |
NCT05640843 |
|
|
39 |
Registry for Adults With Plasma Cell Disorders (PCD's) |
Recruiting |
NCT03717844 |
|
|
40 |
Prospective Observation of the Incidence and Natural History of Monoclonal Gammopathy in Patients Undergoing Weight Reduction Surgery |
Recruiting |
NCT03855878 |
|
|
41 |
Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Myeloma (SMM), and Multiple Myeloma Patient Experience With COVID-19 Survey |
Recruiting |
NCT04727294 |
|
|
42 |
A Prospective Cohort Study of Patients With Plasma Cell Disorders (PCDs) in PKUFH |
Recruiting |
NCT05283993 |
|
|
43 |
Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies |
Recruiting |
NCT05136807 |
|
|
44 |
A Pilot Plant-Based Dietary Intervention in Overweight and Obese Patients With Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple Myeloma (SMM) - The Nutrition Prevention (NUTRIVENTION) Study |
Recruiting |
NCT04920084 |
|
|
45 |
Monoclonal Gammopathies of Renal Significance: Clinical-histological Features of a Multicenter Case Series (MGRS Project) |
Recruiting |
NCT05119309 |
|
|
46 |
Buckeye Surveillance, Contact, and Research for Multiple Myeloma and Amyloidosis |
Recruiting |
NCT01408225 |
|
|
47 |
Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions (TRANSFORMM) |
Recruiting |
NCT05361694 |
|
|
48 |
Characterising Risk and Biology Of Smouldering Myeloma for Early Detection Of Symptomatic Myeloma |
Recruiting |
NCT05047107 |
|
|
49 |
Dysregulation of Glutamine Metabolism in the Pathogenesis of Multiple Myeloma |
Recruiting |
NCT03119883 |
|
|
50 |
Spanish Registry of Patients With Diagnosis of IgM-MGUS, Asymptomatic & Symptomatic Waldenström Macroglobulinemia. Analysis of Clinical and Laboratory Features, Treatment and Outcomes. |
Recruiting |
NCT05093153 |
|
|
|